Literature DB >> 5265376

Serum complement level in patients with leukemia.

S Yoshikawa, K Yamada, T O Yoshida.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5265376     DOI： 10.1002/ijc.2910040613

Source DB:  PubMed          Journal:  Int J Cancer        ISSN： 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  3 in total

1.  Depressed classical complement pathway activities in chronic lymphocytic leukaemia.

Authors:  G Füst; E Czink; D Minh; Z Miszlay; L Varga; S R Hollán
Journal:  Clin Exp Immunol       Date:  1985-06       Impact factor: 4.330

2.  Serum-mediated leukemia cell destruction in AKR mice.

Authors:  R L Kassel; L J Old; E A Carswell; N C Fiore; W D Hardy
Journal:  J Exp Med       Date:  1973-10-01       Impact factor: 14.307

3.  Immunoadherence and complement in cancer-bearing mice.

Authors:  C Porta; M L Villa; E Clerici
Journal:  Br J Cancer       Date:  1978-01       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.